Importantly, this study defined for the first time the molecular mechanism of the observed anti-obesity and insulin-sensitizing effects of trodusquemine, which were shown to result from the potent and selective inhibition of PTP1B. The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.